United States · Funded startup

Who invested in Cue Biopharma

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcarePharma

Raised 4 months ago

Funding summaryUpdated 26 Oct 2026

$76Mraised across 2 rounds since 2017, from 2 sources

$26MRound$50MRound
Latest round
Round, $50MJul 2026
Step-upi
1.9×
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20172019202120232025
$26MRound$50MRound
First round
Round, $26M
Jan 2017
Biggest round
$50M
Round · Jul 2026
Between rounds
9.4 years
from the last two

The rounds

  1. Jul 2026
    Round$50M2 new

    Source recordedSEC filing: $50M sold, first sale May 2026

  2. Jan 2017
    Round$26M1 new

    Reported by FinSMEsSEC filing: $16M sold, first sale Dec 2016

Founders and team

From Cue Biopharma's own website: 4 on the team.

  • James M. AhlersChief Financial Officer
  • Ron OystonChief Administrative Officer
  • Daniel CamardoBoard Member
  • Viola MeehanBoard Member

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

B CapitalVC firm1round
Cormorant Asset ManagementPrivate equity1round
MDB Capital GroupInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Cue Biopharma

Who invested in Cue Biopharma?

Cue Biopharma's investors include B Capital, Cormorant Asset Management and MDB Capital Group.

How much has Cue Biopharma raised?

Cue Biopharma has raised $76M across 2 rounds since 2017.

When did Cue Biopharma last raise?

Cue Biopharma's most recent round was an Undisclosed round of $50M in Jul 2026.

What was Cue Biopharma's biggest round?

Its most recent round, $50M in Jul 2026, is also its largest on record.

Who backed Cue Biopharma first?

Cue Biopharma's first round on record, in Jan 2017, was backed by MDB Capital Group.

What stage is Cue Biopharma at?

Cue Biopharma's latest named round is an Undisclosed round, in Jul 2026.

Where is Cue Biopharma based?

Cue Biopharma is based in the United States.

Companies like Cue Biopharma

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.